menu
    • menu

    Company profile for BioAtla

    NEW Drugs in Dev.: 8
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioAtla® is a San Diego biotech company that develops novel monoclonal antibody and cell based therapeutics using our proprietary Conditionally Active Biologics™ (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!™) platforms. These and other proprietary technologies (protected by more than 150 issued patents and patent applications) allow us to develop novel biologics (CABs) that are better drugs in multiple ...
    BioAtla® is a San Diego biotech company that develops novel monoclonal antibody and cell based therapeutics using our proprietary Conditionally Active Biologics™ (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!™) platforms. These and other proprietary technologies (protected by more than 150 issued patents and patent applications) allow us to develop novel biologics (CABs) that are better drugs in multiple ways including more selective targeting of cancer tissue and improved manufacturability. Improved selectivity for the tumor microenvironment (TME), even when the target is also found in normal tissue.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioAtlaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11085 Torreyana Road San Diego, CA 92121
    Telephone
    Telephone
    +1 858-558-0708
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bioatla.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bioatla/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioAtla & GATC Health Launch $40M (SPV) For Ozuriftamab Vedotin
    BioAtla & GATC Health Launch $40M (SPV) For Ozuriftamab Vedotin

    31 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/31/3211742/0/en/BioAtla-and-GATC-Health-Announce-a-40-Million-Special-Purpose-Vehicle-SPV-Transaction-to-Advance-Ozuriftamab-Vedotin-Oz-V-into-a-Registrational-Trial-for-2L-Oropharyngeal-Squamous-.html

    GLOBENEWSWIRE
    31 Dec 2025
    Share Share
    Bioatla Secures $22.5M Flexible Financing Deals
    Bioatla Secures $22.5M Flexible Financing Deals

    21 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/21/3192511/0/en/BioAtla-Enters-into-Agreements-for-up-to-22-5-Million-Flexible-Financing.html

    GLOBENEWSWIRE
    21 Nov 2025
    Share Share
    Bioatla Reports Q3 2025 Financial Results And Recent Advances
    Bioatla Reports Q3 2025 Financial Results And Recent Advances

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187840/0/en/BioAtla-Reports-Third-Quarter-2025-Financial-Results-and-Highlights-Recent-Progress.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    BioAtla Mec-V Shows 21.5-Month OS In Soft Tissue Sarcoma
    BioAtla Mec-V Shows 21.5-Month OS In Soft Tissue Sarcoma

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183685/0/en/BioAtla-s-Mecbotamab-Vedotin-Mec-V-an-AXL-targeting-ADC-Demonstrates-a-Median-Overall-Survival-OS-of-21-5-months-in-Subtypes-of-Refractory-Soft-Tissue-Sarcomas.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Bioatla To Unveil Q3 2025 Financials & Business Highlights
    Bioatla To Unveil Q3 2025 Financials & Business Highlights

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181399/0/en/BioAtla-to-Announce-Third-Quarter-2025-Financial-Results-and-Provide-Business-Highlights-on-November-13-2025.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    BioAtla Highlights Oz-V ROR2 Targeting Data in OPSCC at IPV Conf
    BioAtla Highlights Oz-V ROR2 Targeting Data in OPSCC at IPV Conf

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3172001/0/en/BioAtla-Presents-Compelling-Mechanistic-Rationale-for-Targeting-ROR2-with-Ozuriftamab-Vedotin-Oz-V-in-Oropharyngeal-Squamous-Cell-Carcinoma-OPSCC-at-the-Annual-Conference-of-the-In.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search